Epicur Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Epicur Pharma's estimated annual revenue is currently $10.3M per year.
- Epicur Pharma's estimated revenue per employee is $201,000
Employee Data
- Epicur Pharma has 51 Employees.
- Epicur Pharma grew their employee count by 6% last year.
Epicur Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Manufacturing Operations and Pharmacist-in-Charge | Reveal Email/Phone |
2 | Director Quality | Reveal Email/Phone |
3 | Chemistry Analyst lll | Reveal Email/Phone |
4 | Veterinary Specialty Representative | Reveal Email/Phone |
5 | Quality Control Analyst II | Reveal Email/Phone |
6 | Veterinary Sales Representative | Reveal Email/Phone |
7 | Aseptic Manufacturing Supervisor | Reveal Email/Phone |
8 | iFill Support Specialist | Reveal Email/Phone |
9 | Lead Quality Assurance Analyst | Reveal Email/Phone |
10 | Microbiology Supervisor | Reveal Email/Phone |
Epicur Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Epicur Pharma?
Epicur Pharma, a division of Stokes Healthcare, is a mini-manufacturer, producing drugs such as Tacrolimus Eyedrops, Buprenorphine Injection and Gabapentin tablets. Epicur is overseen by the FDA and is considered a 503B Registered Outsourcing Facility.
keywords:N/AN/A
Total Funding
51
Number of Employees
$10.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5M | 55 | 8% | N/A |
#2 | $11.1M | 56 | 2% | N/A |
#3 | $16.2M | 77 | 133% | N/A |
#4 | $8.3M | 83 | 26% | N/A |
#5 | $27.1M | 88 | 0% | N/A |